WAT

SELL

Waters Corporation

Healthcare · Rank #302 · Analyzed Oct 18, 2026

$436.95

Current Price

$84.30

Intrinsic Value

-80.7%

Upside/Downside

2/10

Score

2/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score2/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 80.7%

Fair Value Range

Low$42.15

Base (IV)$84.30

High$109.58

Entry Points

Conservative$29.50

Moderate$42.15

Aggressive$59.01

Quality & Moat Breakdown

Return on Equity1.9% → 0/1.0

Debt LevelD/E 36 → 0.5/1.0

Revenue QualityGrowth 7.1%, margin Δ-0.6% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins3.6% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.